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Abstract To investigate in type-1 diabetes mellitus
(DM1) patients the role of hypertension and of DM1
itself on aortic stiffness by using magnetic resonance
imaging (MRI). Consecutive patients from the dia-
betes and hypertension outpatient clinic and healthy
volunteers were included in our study. Subjects were
divided into four groups: 32 healthy volunteers (mean
age: 54.5 ± 6.8 years), 20 DM1 patients (mean age:
48.3 ± 5.9 years), 31 hypertensive patients (mean
age: 59.9 ± 7.2 years) and 28 patients with both
DM1 and hypertension (mean age: 50.1 ± 6.2 years).
Aortic stiffness was measured by means of pulse
wave velocity (PWV) using velocity-encoded MRI.
Analysis of variance (ANOVA), uni- and multivar-
iable regression models and the Bonferroni-test for
multiple testing, were used for statistical analyses.
Mean aortic PWV was 5.7 ± 1.2 m/s in healthy
volunteers, 5.9 ± 1.2 m/s in DM1 patients without
hypertension, 7.3 ± 1.2 m/s in hypertensive patients
and 7.3 ± 1.3 m/s in patients with both DM1 and
hypertension. Compared to healthy control subjects,
aortic PWV was signiﬁcantly higher in patients with
hypertension (P\0.001) and in patients with both
DM1 and hypertension (P\0.001), whereas aortic
PWV was not increased in patients having DM1
alone. Furthermore, aortic PWV was signiﬁcantly
higher in DM1 patients with hypertension than in
patients with DM1 alone (P = 0.002). These ﬁndings
remained after adjustment for confounding factors.
Hypertension has a predominant contributive effect
on aortic stiffness in DM1 patients whereas the direct
diabetic effect on aortic stiffness is small.
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Introduction
Increased aortic stiffness is an important risk factor
for adverse cardiovascular outcome in various disease
states including diabetes mellitus (DM) [1–3].
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DOI 10.1007/s10554-011-9841-2Studies have demonstrated that aortic stiffness is
increased in patients with particularly type-2 DM
(DM2) [1, 4]. However, DM2 is commonly associ-
ated with other classical risk factors such as obesity,
abnormal lipid status and hypertension that also may
affect aortic stiffness [1, 5–7].
Cardiovascular risk proﬁles in patients with type-1
DM (DM1) usually differ from that in patients with
DM2, but similar ﬁndings with respect to increased
aortic stiffness have been found [3, 8–13]. An MRI
study has recently shown that aortic stiffness is
associated with cerebrovascular and cardiovascular
end-organ damage in DM1 patients [3]. In these DM1
patient studies, the increase in aortic stiffness was
relatively minor as compared to other patient groups,
such as in patients with DM2 and in patients with
hypertension [2, 3, 14, 15]. Also, in DM1 patients
increased aortic stiffness has been measured in young
DM1 patients or in DM1 patients with microvascular
complications [2, 8–13]. Therefore, it is conceivable
that like in DM2 patients, confounding factors may
play a dominant role in aortic stiffness of DM1
patients as well.
A recent systematic review on aortic stiffness risk
factors has demonstrated that age and hypertension
are major and independent risk factors for aortic
stiffness, while the association between DM (partic-
ularly DM2), obesity and abnormal lipid proﬁles with
aortic stiffness were found moderate [16]. The
hypothesis of our study is that hypertension also has
a predominant effect on aortic stiffness in DM1
patients. To what extent DM1 itself independently
adds to aortic stiffness remains to be established.
Having knowledge of dominant factors affecting
aortic stiffness in DM1 patients may be of value in
guiding therapy, which is relevant considering the
increased cardiovascular risk status in DM1 patients
with increased aortic stiffness.
A widely used parameter expressing aortic stiff-
ness is the pulse wave velocity (PWV), which is
deﬁned as the propagation speed of the pressure or
ﬂow wave front traveling along the aorta [17]. PWV
is estimated by dividing the distance between
anatomical locations over the aorta by the time
difference between the ﬂow waves at the two
locations and is often determined by carotid-femoral
PWV with means of ultrasound. However unlike
ultrasound, magnetic resonance imaging (MRI) has
full access to the thoracic cavity enabling
quantiﬁcation of direct aortic function without the
need for geometrical assumptions. With MRI, PWV
can be accurately and directly measured in the aorta
[18].
The purpose of our study was to investigate in
DM1 patients the role of hypertension and of DM1
itself on aortic PWV by using MRI.
Methods
Study population
This study was approved by the local medical ethics
committee and all subjects gave informed consent to
participate in the study. Consecutive patients, diag-
nosed with DM1 and essential hypertension, from the
diabetes and hypertension outpatient clinic were
eligible in our study. Healthy volunteers were also
eligible and recruited by advertisement in local
newspapers. All subjects were within the age range
of 40–70 years and underwent MRI of the aorta
between January 2005 and October 2009.
Subjects were divided into 4 subgroups based on
the following criteria: group 1, healthy volunteers
(N = 32); group 2, patients with DM1 (N = 20);
group 3, patients with hypertension (N = 31); group
4, patients with both DM1 and hypertension
(N = 28). The effect of DM1 and hypertension on
aortic stiffness was investigated by comparing aortic
PWV between the groups.
DM1 was deﬁned as fasting blood glucose
C7.0 mmol/l according to WHO criteria [19]. Hyper-
tension was deﬁned as: systolic blood pressure
[140 mm Hg and/or diastolic blood pressure [90
mm Hg, on repeated physical examination before
antihypertensive therapy was instituted and according
to criteria of the European Society of Hypertension
(ESH) [20], or blood pressure above 140/90 mmHg at
time of MRI. All diabetic patients were on treatment
with insulin and all hypertensive patients were on
treatment with antihypertensive medication. Blood
pressure was measured at the time of MRI using
a semi-automated sphygmomanometer (Dinamap,
Critikon, Tampa, Florida, USA). Pulse pressure was
deﬁned as: systolic blood pressure–diastolic blood
pressure. Furthermore, smoking status (i.e. non-
smoker or current smoker), body mass index (BMI),
glycated hemoglobin (HbA1c), total cholesterol, the
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123cholesterol to high-density lipoprotein (Cholesterol/
HDL) ratio, triglycerides and C-reactive protein were
determined. Blood was drawn in the morning after
an overnight fast within 2 weeks before MRI. The
albumin excretion ratio was calculated using the
microalbumin and creatinin concentrations in
the urine.
Healthy volunteers underwent similar work-up as
DM1 or hypertensive patients. Healthy volunteers did
not comprise subjects with DM1, hypertension,
cardiovascular disease, left ventricular hypertrophy
as evaluated by means of electrocardiography or MRI
or any systemic disease.
Exclusion criteria comprised of known history of
cardiovascular disease, evidence of aortic valve
stenosis or insufﬁciency, as evaluated by means of
physical examination and velocity-encoded MRI,
Marfan syndrome, aortic coarctation or any aortic
disease, known history of other systemic diseases
than DM1 or hypertension and general contraindica-
tions to MRI.
MRI protocol
Aortic PWV was assessed using a 1.5-T MRI scanner
(NT 15 Gyroscan Intera; Philips Medical Systems,
Best, the Netherlands) as previously described [18].
In short, ﬁrst a longitudinal image of the aorta was
acquired during a breath-hold using a segmented
gradient-echo sequence. Scan parameters were: rep-
etition time (TR) 4.0 ms, echo time (TE) 1.05 ms,
ﬂip angle (FA) 30
o, ﬁeld-of-view (FOV) 450 mm,
128 9 128 acquisition matrix, reconstructed to
256 9 256, slice thickness 15 mm and 2 number of
signal averaged (NSA) using a ﬁve-element phased
array cardiac surface coil. Then, a retrospectively
electrocardiographic-gated gradient-echo sequence
with velocity encoding perpendicular to the aorta
was applied to measure through-plane ﬂow at two
predeﬁned levels: 1) at the level of the ascending
aorta 2) at the level of the distal abdominal aorta.
Scan parameters were: TR 5.0 ms, TE 2.9 ms, FA
20, FOV 300 mm, 128 9 115 acquisition matrix,
reconstructed to 256 9 256, slice thickness 8 mm
with maximal number of phases reconstructed ensur-
ing high (6–10 ms) temporal resolution. Maximum
velocity encoding (Venc) was set to 150 cm/s at the
ascending aorta level and 100 cm/s at the abdominal
aorta level, respectively.
Image analyses
PWV was calculated using the following formula:
Dx/Dt (m/s), where Dx describes the distance
between the ascending aorta and the distal abdominal
aorta and Dt describes the transit time between the
arrival of the pulse wave at these respective sites. The
aortic path length between the measurements sites
was determined from a centerline manually posi-
tioned along the aorta using the software package
MASS (Medis) [21]. Aortic velocity maps were
analyzed using the in-house developed software
package FLOW (Medis) [21]. The onset of the
systolic wave front was automatically determined
from the resulting ﬂow graph by the intersection point
of the constant diastolic ﬂow and upslope of the
systolic wave front, modeled by linear regression
along the steepest part of the upslope.
Manual contour drawing in the aorta velocity maps
was performed by two researchers (A.B. and S.v.E.,
both 3 year experience in cardiac MRI) and super-
vised by a senior researcher (J.J.W. 15 years expe-
rience in cardiac MRI), all unaware of the subjects’
conditions.
Statistical analyses
Statistical analysis was performed using SPSS for
Windows (version 17.0; SPSS, Chicago, Illinois,
USA). Data are expressed as mean ± standard devi-
ation (SD) unless stated otherwise. Aortic PWV data
were nonnormally distributed and further analyses
were performed using the log-transformed PWV data.
Analyses of variance (ANOVA) were used to calcu-
late the differences between the groups concerning
aortic PWV and continuous variables. The chi-square
test was used to calculate the difference in dichoto-
mous variables between groups. Pearson and Spear-
man correlation analyses were performed to analyze
the association between aortic PWV and continuous
and dichotomous variables, respectively. Pearson or
Spearman correlation coefﬁcients (r) and P-values are
reported.
Univarible and multivariable regression models
were used to correct for possible confounding factors.
Age and sex were considered as standard confound-
ing factors. Furthermore, clinical and laboratory
variables that were statistically signiﬁcantly different
between groups (i.e. with ANOVA) and were related
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123to outcome (i.e. with aortic PWV in Pearson or
Spearman correlation analyses) were considered as
confounding factors.
To estimate the effect of DM1, hypertension, and
DM1 with hypertension on aortic PWV, healthy
volunteers were used as the reference category. To
estimate the additional effect of DM1 or hypertension
on aortic PWV, DM1 patients with hypertension were
used as the reference category. Overall P-values and
mean ± standard errors (SE) are reported. The Bon-
ferroni-test was used to correct for multiple testing. A
P\0.05 was considered statistically signiﬁcant.
Results
Clinical characteristics
Table 1 describes the clinical characteristics of the
study population per subgroup. Age was signiﬁcantly
higher in healthy volunteers and in patients with
hypertension as compared to DM1 patients with and
without hypertension. The group of healthy volun-
teers comprised of a higher male/female ratio than the
other groups. Systolic blood pressure, diastolic blood
pressure and pulse pressure were inherently increased
in the hypertensive groups. HbA1c was inherently
higher in the groups including DM1 patients. Fur-
thermore, lipid proﬁles were different between
groups.
Association between aortic PWV and clinical
and laboratory parameters
Aortic PWV was signiﬁcantly associated with age
(r = 0.4, P\0.001), systolic blood pressure (r = 0.5,
P\0.001), diastolic blood pressure (r = 0.3, P =
0.002), pulse pressure (r = 0.4, P\0.001) and tri-
glycerides (r = 0.2, P = 0.012). As pulse pressure is a
resultant of systolic blood pressure minus diastolic
Table 1 Clinical characteristics of the study population per subgroup
Healthy volunteers
(N = 32)
DM1
(N = 20)
Hypertension
(N = 31)
DM1 and hypertension
(N = 28)
P-value
Age (years) 54.5 ± 6.8 48.3 ± 5.9 59.9 ± 7.2 50.1 ± 6.2 \0.001*
Sex
Male 24 (75) 8 (40) 10 (37) 15 (54) 0.016*
Female 8 (25) 12 (60) 17 (63) 13 (46)
Systolic blood pressure
(mmHg)
118 ± 11 120 ± 10 165 ± 18 141 ± 19 \0.001*
Diastolic blood pressure
(mmHg)
76 ± 96 9 ± 79 6 ± 13 76 ± 10 \0.001*
Pulse Pressure (mmHg) 42 ± 12 51 ± 96 9 ± 19 64 ± 15 \0.001*
Smoking
No 28 (87) 18 (90) 22 (81) 23 (22) 0.830
Yes 4 (13) 2 (10) 5 (19) 5 (18)
Body mass index (kg/m2) 26.9 ± 3.0 24.4 ± 2.1 26.0 ± 4.7 26.5 ± 3.4 0.087
HbA1c (%) 5.4 ± 0.2 7.0 ± 1.0 5.2 ± 0.3 7.8 ± 1.0 \0.001*
Cholesterol (mmol/l) 5.3 ± 0.9 4.5 ± 0.7 5.6 ± 1.0 4.9 ± 1.0 0.001*
Cholesterol/HDL ratio
(mmol/l)
3.7 ± 1.0 2.8 ± 0.6 3.7 ± 1.1 3.2 ± 1.0 0.003*
Triglycerides (mmol/l) 1.1 ± 0.5 0.9 ± 0.3 1.4 ± 0.4 1.6 ± 1.0 \0.001*
C-reactive protein 1.9 ± 1.8 1.6 ± 1.5 2.4 ± 2.7 2.7 ± 3.7 0.466
Microalbuminuria 1.5 ± 2.1 1.0 ± 1.5 2.3 ± 4.4 1.8 ± 3.2 0.567
Values are mean ± SD or data are numbers of patients and numbers in parentheses are percentages
DM1 Type–1 Diabetes mellitus patients, HbA1c Glycated hemoglobin, HDL high density lipoprotein
*P-value\0.05
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123blood pressure, pulse pressure was considered as a
confounding factor, whereas systolic and diastolic
blood pressure were not. Sex, smoking status, BMI,
HbA1c, lipid status, C-reactive protein and microal-
buminuria did not correlate with aortic PWV.
Independent and combined effect of DM1
and hypertension on aortic PWV
Mean aortic PWV was 5.7 ± 1.2 m/s in healthy
subjects, 5.9 ± 1.2 m/s in DM1 patients, 7.3 ± 1.2
m/s in hypertensive patients without diabetes and
7.3 ± 1.3 m/s in DM1 patients with hypertension.
Table 2 describes the uni- and multivariable regres-
sion models for assessment of the independent and
combined effect of DM1 and hypertension on aortic
stiffness, before and after correction for confounding
factors.
Without correction for confounding factors, aortic
PWV was statistically signiﬁcantly higher in patients
withhypertension(P\0.001)andinpatientswithboth
DM1 and hypertension (P\0.001), but not in patients
having only DM1 (P = 0.528) as compared to healthy
volunteers (Table 2a). Furthermore, aortic PWV was
statistically signiﬁcantly higher in DM1 patients with
hypertensionascomparedtoDM1patients(P = 0.002),
whereas aortic PWV was not statistically signiﬁcantly
different between DM1 patients with hypertension and
hypertensive patients (Table 2b).
Aftercorrectionforstandardconfoundingfactorsage
and sex, the differences in aortic PWV remained
comparable between groups (Table 2). Mean aortic
PWV was 5.4 ± 1.0 m/s in healthy subjects, 6.3 ±
1.1 m/sinDM1patients,7.2 ± 1.0 m/sinhypertensive
patients and 7.3 ± 1.0 m/s in DM1 patients with
hypertension. Figure 1 shows the difference between
the groups regarding aortic PWV corrected for age and
sex; having DM1 alone does not statistically signiﬁ-
cantly affect aortic PWV as compared to healthy
volunteers, although a slight trend for increased aortic
PWV in DM1 patients as compared to healthy volun-
teers can be observed. Conversely, hypertension has
major effect in increasing aortic PWV (Fig. 1).
After correction for age, gender, pulse pressure
and triglycerides mean aortic PWV was 5.6 ± 1.1 m/s
in healthy subjects, 6.4 ± 1.1 m/s in DM1 patients,
7.1 ± 1.0 m/s in hypertensive patients without dia-
betes and 7.2 ± 1.0 m/s in DM1 patients with
hypertension. Additionally correcting for pulse pres-
sure and triglycerides as confounding factors, had
effect on the difference in aortic PWV between DM1
patients with hypertension and patients having only
DM1, which was no longer statistically signiﬁcantly
different from each other (Table 2b). This was
expected because pulse pressure and triglycerides
are inherently increased in subgroups with DM1 and
hypertension; by correcting for these confounders
group outcomes were equalized.
Discussion
We investigated the independent and combined effect
of DM1 and hypertension on aortic stiffness by
Table 2 Difference in aortic PWV between subgroups before and after correction for confounding factors
Reference category Uncorrected
model
Model corrected
for age and sex
Model corrected for age, sex,
pulse pressure and triglycerides
P-value P-value P-value
a. Healthy volunteers
DM1 patients 0.528 0.058 0.198
Hypertensive patients \0.001* \0.001* \0.001*
DM1 patients with hypertension \0.001* \0.001* \0.001*
b. DM1 patients with hypertension
Hypertensive patients 0.665 0.668 0.668
DM1 patients 0.002* 0.030* 0.228
DM1: type–1 diabetes mellitus patients
* P-value\0.05
a. Healthy volunteers serve as the reference category; b. DM1 patients with hypertension serve as the reference category
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123comparing four subgroups including DM1 patients
with and without hypertension, hypertensive patients
and healthy volunteers by using MRI. The main
ﬁnding was that the independent effect of DM1 on
aortic PWV was minor; aortic PWV was not signif-
icantly different between healthy volunteers and
DM1 patients. In addition, no differences were found
in aortic PWV between DM1 patients with hyperten-
sion and hypertensive patients that remained after
correction for confounding factors age, gender, pulse
pressure and triglycerides. Secondly, the independent
effect of hypertension on aortic PWV was major;
aortic PWV was signiﬁcantly higher in hypertensive
patients than in healthy volunteers. In addition, the
combination of DM1 and hypertension resulted in
increased aortic stiffness, and was signiﬁcantly
higher than in patients having DM1 alone, that
remained after correction for age and sex.
Previous studies have demonstrated increased
aortic stiffness in DM1 patients with microvascular
complications including microalbuminuria or hyper-
tension as compared to healthy volunteers [2, 8–13].
Age and hypertension are well-established risk fac-
tors of aortic stiffness and hypertension is often
present in DM1. It is therefore conceivable that
multiple factors may contribute to aortic stiffness in
DM1 patients. We investigated the effect of DM1
itself on aortic PWV by evaluating a relatively well-
controlled, uncomplicated DM1 patient group with an
age range between 40 and 70 years old. In DM1
patients, aortic stiffness was not signiﬁcantly differ-
ent from healthy volunteers although a trend towards
increased aortic stiffness was observed after correc-
tion for age and sex. When comparing subgroups,
triglycerides and pulse pressure were inherently
increased in patients with hypertension. Therefore,
after additional correction for triglycerides and pulse
pressure, differences between DM1 patients with
hypertension and patients having DM1 alone became
non-signiﬁcant, that was explained by equalizing
subgroups.
Hypertension is a well-known major and indepen-
dent risk factor for aortic stiffness [16, 22], that was
also found in our study. Investigating the hyperten-
sive contribution on aortic stiffness in patients with
DM1 is relevant for cardiovascular risk assessment,
as DM1 is often associated with hypertension,
especially in the elderly [2, 16]. Age and blood
pressure have consistently been shown to be inde-
pendently associated with PWV [16]. The impact of
hypertension on aortic stiffening may be twofold: 1.
mechanistic stretching of the arterial wall may result
in aortic stiffening; 2. structural changes of the
arterial wall due to cyclic stress, resulting in stress
fracturing of elastin and consequent stiffening
[16, 23]. In contrast to the predominant effect of
hypertension on aortic stiffening, only weak correla-
tions have been shown with diabetes, accounting for a
mean of 5% of the variation in PWV [16]. It is
generally believed that increased aortic stiffness
plays an important role in the pathway linking
various diseases, including DM1 with increased
cardiovascular risk factors [1, 2]. We have now
demonstrated that aortic stiffness in DM1 patients
mainly depends on having additional hypertension,
and not on DM1 alone. Thus, identiﬁcation of
hypertension in patients with DM1 is of importance
for risk stratiﬁcation and may be used for stratifying
therapy as to improve cardiovascular outcome.
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Fig. 1 Difference in aortic PWV between subgroups corrected
for age and sex. V Healthy volunteers, DM1 type-1 diabetes
mellitus patients, HT hypertension patients, DM1HT type-1
diabetes mellitus patients with hypertension. Means ± SE per
subgroup are given and P-values between subgroups are
presented below. * P\0.05. ns: non-signiﬁcant
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123Some study limitations are addressed. This study
has a cross-sectional design. Therefore, direct causa-
tive mechanisms of the effect of DM1 itself and of
hypertension cannot be determined. Follow-up studies
are required for further evaluation of the role of DM1
and hypertension on aortic stiffness. From our study
design with four subgroups it was difﬁcult to exactly
age- and gender match all patients and volunteers.
Therefore, multivariable regression models were used
to account for possible confounding factors, including
age.Aftercorrectionforageandsex,thedifferencesin
aorticPWVremained comparablebetweensubgroups.
In conclusion, hypertension has a predominant
contributive effect on aortic stiffness in DM1 patients
whereas the direct diabetic effect on aortic stiffness is
small. As aortic stiffness and DM1 are highly
associated with adverse cardiovascular outcome,
identifying hypertension in DM1 patients seems
highly relevant for risk stratiﬁcation.
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